AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) Stock Price Up 0.3% – What’s Next?

AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTALGet Free Report)’s share price rose 0.3% during mid-day trading on Tuesday . The stock traded as high as $14.55 and last traded at $14.52. Approximately 255,095 shares traded hands during trading, a decline of 66% from the average daily volume of 760,484 shares. The stock had previously closed at $14.48.

AGF U.S. Market Neutral Anti-Beta Fund Stock Up 0.1%

The firm’s fifty day moving average price is $14.97 and its 200 day moving average price is $16.08. The stock has a market cap of $363.25 million, a PE ratio of 17.67 and a beta of -0.66.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. PMV Capital Advisers LLC raised its position in shares of AGF U.S. Market Neutral Anti-Beta Fund by 35.5% during the 3rd quarter. PMV Capital Advisers LLC now owns 204,763 shares of the company’s stock valued at $3,260,000 after buying an additional 53,603 shares in the last quarter. Magnolia Private Wealth LLC grew its position in AGF U.S. Market Neutral Anti-Beta Fund by 266.0% in the second quarter. Magnolia Private Wealth LLC now owns 68,189 shares of the company’s stock worth $1,207,000 after acquiring an additional 49,560 shares in the last quarter. L.M. Kohn & Company bought a new stake in AGF U.S. Market Neutral Anti-Beta Fund during the second quarter worth approximately $570,000. Creative Financial Designs Inc. ADV increased its stake in AGF U.S. Market Neutral Anti-Beta Fund by 2.5% during the third quarter. Creative Financial Designs Inc. ADV now owns 224,292 shares of the company’s stock worth $3,571,000 after acquiring an additional 5,487 shares during the last quarter. Finally, Ethos Financial Group LLC raised its position in AGF U.S. Market Neutral Anti-Beta Fund by 24.7% during the second quarter. Ethos Financial Group LLC now owns 25,229 shares of the company’s stock valued at $446,000 after purchasing an additional 5,004 shares during the period.

About AGF U.S. Market Neutral Anti-Beta Fund

(Get Free Report)

The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.

Featured Articles

Receive News & Ratings for AGF U.S. Market Neutral Anti-Beta Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AGF U.S. Market Neutral Anti-Beta Fund and related companies with MarketBeat.com's FREE daily email newsletter.